Patients News | pharmaphorum

News

MHRA imposes restrictions on acne drug in children

The UK medicines regulator has tightened up controls on the prescription of acne treatment isotretinoin to patients under the age of 18, following a review prompted by con

News

After period of decline, dementia may be on the rise again

While there is widespread fear of an explosion in dementia cases as the global population ages, there has actually been a downward trend in Europe and North America in the

News

EMA finds no evidence GLP-1 agonists cause thyroid cancer

The EMA’s safety committee has said that, after a review of available data, it has found no evidence that GLP-1 agonist drugs such as Novo Nordisk’s Ozempic and Eli Lilly’

News

Early result backs Regeneron’s deafness gene therapy

Regeneron’s gene therapy for a profound form of deafness affecting children, DB-OTO, has shown the first signs that it can improve hearing in a clinical trial.

News

NICE backs pump-based Parkinson’s drug from AbbVie

A therapy for Parkinson’s disease that can be delivered by a 24-hour subcutaneous infusion pump has been recommended for use by the NHS and could be an option for hundreds

News

GSK targets younger age group with RSV jab Arexvy

GSK has reported new clinical data pointing to a benefit with its respiratory syncytial virus (RSV) vaccine Arexvy when used to treat a younger age group than the over-60s

MHRA imposes restrictions on acne drug in children

After period of decline, dementia may be on the rise again

EMA finds no evidence GLP-1 agonists cause thyroid cancer

Early result backs Regeneron’s deafness gene therapy

NICE backs pump-based Parkinson’s drug from AbbVie

GSK targets younger age group with RSV jab Arexvy

Ultragenyx to slash costs after Angelman trial failure

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks